연구성과로 돌아가기

2024 연구자 정보 (821 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Park, Sun Hee
(Park, SH)
Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea
0000-0001-5648-9237
Park, Sun Hee
[JCR상위 37.6] COVID-19 Vaccination Recommendations for 2024-2025 in Korea ESCI 37.6 INFECTIOUS DISEASES wbpark1@snu.ac.kr;
Park, Sun Hyo
(Park, SH)
Keimyung Univ, Sch Med, Dept Internal Med, Busan, South Korea JVN-6216-2024
Park, Sun Hyo

[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study
[JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC
SCIE 37.6 ONCOLOGY fireajh@gmail.com;
ejspulm@pusan.ac.kr;fireajh@gmail.com;
Park, Wan Beom
(Park, WB)
제1저자 교신저자 Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
GLU-9886-2022
Park, Wan Beom

[JCR상위 37.6] COVID-19 Vaccination Recommendations for 2024-2025 in Korea
[JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition
ESCI 37.6 INFECTIOUS DISEASES wbpark1@snu.ac.kr;
heejinmd@korea.ac.kr;
Seo, Jun -Won
(Seo, JW)
제1저자 Chosun Univ, Coll Med, Dept Internal Med, Div Infect Dis, Gwangju, South Korea

[JCR상위 37.6] Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID ESCI 37.6 INFECTIOUS DISEASES infection@korea.ac.kr;
Seo, Yu Jin
(Seo, YJ)
Kyungpook Natl Univ, Dept Stat, Daegu, South Korea

[JCR상위 37.6] Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study
[JCR상위 18.1] The impact of shortening patient-doctor contact duration on early peritoneal dialysis-related infections
[JCR상위 8.6] Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched Study
[JCR상위 15.4] Phosphate level predicts mortality in acute kidney injury patients undergoing continuous kidney replacement therapy and has a U-shaped association with mortality in patients with high disease severity: a multicenter retrospective study
ESCI
SCIE
8.6 INFECTIOUS DISEASES
MULTIDISCIPLINARY SCIENCES
UROLOGY & NEPHROLOGY
ktkwon@knu.ac.kr;
sh-park@knu.ac.kr;ylkim@knu.ac.kr;
jh-cho@knu.ac.kr;
imyongkim@gmail.com;jh-lim@knu.ac.kr;
Seol, Hee Yun
(Seol, HY)
Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea
Pusan Natl Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med,Yangsan Hosp, Yangsan, South Korea


[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study
[JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC
SCIE 37.6 ONCOLOGY fireajh@gmail.com;
ejspulm@pusan.ac.kr;fireajh@gmail.com;
Shah, Zunairah
(Shah, Z)
Roswell Pk Comprehens Care Ctr, Dept Hematol Oncol, Buffalo, NY USA

[JCR상위 37.6] Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy SCIE 37.6 ONCOLOGY YCHAE@nm.org;
Shin, Kyeong-Cheol
(Shin, KC)
Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea

[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study
[JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC
SCIE 37.6 ONCOLOGY fireajh@gmail.com;
ejspulm@pusan.ac.kr;fireajh@gmail.com;
Song, Ga-Young
(Song, GY)
Chonnam Natl Univ, Dept Hematol, Hwasun Hosp, Gwangju, Chollanamdo, South Korea
Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Med Sch, Gwangju, Jeollanam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Hwasun, South Korea


[JCR상위 37.6] Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era
[JCR상위 18.1] Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
[JCR상위 23.3] Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
SCIE 18.1 ONCOLOGY
MULTIDISCIPLINARY SCIENCES
MEDICINE, GENERAL & INTERNAL
drydh1685@hotmail.com;
f0115@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Yang, Deok-Hwan
(Yang, DH)
교신저자 Chonnam Natl Univ, Dept Hematol, Hwasun Hosp, Gwangju, Chollanamdo, South Korea
Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Med Sch, Gwangju, Jeollanam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Hwasun, South Korea
Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Hwasun, South Korea
Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, 322 Seoyang Ro, Hwasun 58128, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Hematol & Oncol, Hwasun, South Korea
Chonnam Natl Univ, Med Sch, Med Sch, Hwasun Hosp, Gwangju, Jeonranam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Jeollanam Do, South Korea

0000-0003-2830-9889
Yang, Deok-Hwan
[JCR상위 37.6] Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era
[JCR상위 18.1] Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
[JCR상위 24.0] Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma
[JCR상위 23.3] Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
[JCR상위 1.5] Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon
[JCR상위 1.5] Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b
[JCR상위 1.5] Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea
SCIE 1.5 ONCOLOGY
MULTIDISCIPLINARY SCIENCES
HEMATOLOGY
MEDICINE, GENERAL & INTERNAL
drydh1685@hotmail.com;
f0115@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
wskimsmc@skku.edu;
Yeom, Joon Sup
(Yeom, JS)
Yonsei Univ, Dept Internal Med, Div Infect Dis, Coll Med, Seoul, South Korea Q-5559-2019
Yeom, Joon
0000-0001-8940-7170
Yeom, Joon Sup
[JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition ESCI 37.6 INFECTIOUS DISEASES heejinmd@korea.ac.kr;
Yhim, Ho-Young
(Yhim, HY)
Jeonbuk Natl Univ, Med Sch, Dept Internal Med, Jeonju, South Korea
Jeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea
Hallym Univ Sacred Heart Hosp, xyang Si, South Korea
J-1531-2012
Yhim, Ho-Young

[JCR상위 37.6] Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era
[JCR상위 37.2] Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study
[JCR상위 23.3] Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
[JCR상위 1.5] Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment
SCIE 1.5 ONCOLOGY
HEMATOLOGY;ONCOLOGY
MEDICINE, GENERAL & INTERNAL
HEMATOLOGY
drydh1685@hotmail.com;
kihyunkimk@gmail.com;
Yoo, Jae-sung
(Yoo, JS)
Kyungpook Natl Univ, Sch Med, Daegu, South Korea

[JCR상위 37.6] Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma SCIE 37.6 ONCOLOGY oj-cumc@daum.net;pssung@catholic.ac.kr;
Yoon, Seong-Mi
(Yoon, SM)
ORTHOTECH, Med Res Inst, Med Ctr, Dept Pathol, Daegu, South Korea

[JCR상위 37.6] Roadmap for providing and leveraging annotated data by cytologists in the PDAC domain as open data: support for AI-based pathology image analysis development and data utilization strategies SCIE 37.6 ONCOLOGY jeongsm00@gmail.com;
Ban, Sanghyun
(Ban, SHY)
Pohang Univ Sci & Technol POSTECH, Ctr Single Atom Based Semicond Device, Dept Mat Sci & Engn, Pohang 790784, South Korea JDN-0699-2023
Ban, Sanghyun
0000-0001-9940-9911
Ban, Sanghyun
[JCR상위 37.7] Understanding Switching Mechanism of Selector-Only Memory Using Se-Based Ovonic Threshold Switch Device SCIE 37.7 ENGINEERING, ELECTRICAL & ELECTRONIC;PHYSICS, APPLIED jangsub@postech.ac.kr;hwanghs@postech.ac.kr;
페이지 이동: